233 related articles for article (PubMed ID: 21575980)
1. Adenoviruses induce autophagy to promote virus replication and oncolysis.
Rodriguez-Rocha H; Gomez-Gutierrez JG; Garcia-Garcia A; Rao XM; Chen L; McMasters KM; Zhou HS
Virology; 2011 Jul; 416(1-2):9-15. PubMed ID: 21575980
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the roles of E1A and E1B in adenoviral replication and RCAd-enhanced RDAd transduction efficacy on tumor cells.
Wei F; Wang H; Chen X; Li C; Huang Q
Cancer Biol Ther; 2014 Oct; 15(10):1358-66. PubMed ID: 25019940
[TBL] [Abstract][Full Text] [Related]
3. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.
Wakayama M; Abei M; Kawashima R; Seo E; Fukuda K; Ugai H; Murata T; Tanaka N; Hyodo I; Hamada H; Yokoyama KK
Clin Cancer Res; 2007 May; 13(10):3043-50. PubMed ID: 17505007
[TBL] [Abstract][Full Text] [Related]
4. The role of JNK phosphorylation as a molecular target to enhance adenovirus replication, oncolysis and cancer therapeutic efficacy.
Wechman SL; Rao XM; Gomez-Gutierrez JG; Zhou HS; McMasters KM
Cancer Biol Ther; 2018; 19(12):1174-1184. PubMed ID: 30067431
[TBL] [Abstract][Full Text] [Related]
5. E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects.
Kim J; Kim JH; Choi KJ; Kim PH; Yun CO
Hum Gene Ther; 2007 Sep; 18(9):773-86. PubMed ID: 17725410
[TBL] [Abstract][Full Text] [Related]
6. The human adenovirus type 5 E1B 55 kDa protein obstructs inhibition of viral replication by type I interferon in normal human cells.
Chahal JS; Qi J; Flint SJ
PLoS Pathog; 2012; 8(8):e1002853. PubMed ID: 22912576
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic virotherapy for prostate cancer by E1A, E1B mutant adenovirus.
Satoh M; Wang H; Ishidoya S; Abe H; Moriya T; Hamada H; Arai Y
Urology; 2007 Dec; 70(6):1243-8. PubMed ID: 18158069
[TBL] [Abstract][Full Text] [Related]
8. E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer.
Fukuda K; Abei M; Ugai H; Kawashima R; Seo E; Wakayama M; Murata T; Endo S; Hamada H; Hyodo I; Yokoyama KK
Cancer Gene Ther; 2009 Feb; 16(2):126-36. PubMed ID: 18818710
[TBL] [Abstract][Full Text] [Related]
9. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic adenovirus-induced autophagy: tumor-suppressive effect and molecular basis.
Tazawa H; Kagawa S; Fujiwara T
Acta Med Okayama; 2013; 67(6):333-42. PubMed ID: 24356717
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B Virus Subverts the Autophagy Elongation Complex Atg5-12/16L1 and Does Not Require Atg8/LC3 Lipidation for Viral Maturation.
Döring T; Zeyen L; Bartusch C; Prange R
J Virol; 2018 Apr; 92(7):. PubMed ID: 29367244
[TBL] [Abstract][Full Text] [Related]
12. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
13. HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.
Xu HN; Huang WD; Cai Y; Ding M; Gu JF; Wei N; Sun LY; Cao X; Li HG; Zhang KJ; Liu XR; Liu XY
Mol Cancer; 2011 Nov; 10():133. PubMed ID: 22040050
[TBL] [Abstract][Full Text] [Related]
14. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic Replication of E1b-Deleted Adenoviruses.
Cheng PH; Wechman SL; McMasters KM; Zhou HS
Viruses; 2015 Nov; 7(11):5767-79. PubMed ID: 26561828
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 and HIV-2 infections induce autophagy in Jurkat and CD4+ T cells.
Wang X; Gao Y; Tan J; Devadas K; Ragupathy V; Takeda K; Zhao J; Hewlett I
Cell Signal; 2012 Jul; 24(7):1414-9. PubMed ID: 22406083
[TBL] [Abstract][Full Text] [Related]
17. The antitumor efficacy of IL-24 mediated by E1A and E1B triple regulated oncolytic adenovirus.
Xiao LL; Wu YM; Qian J; Tan Y; Xie GL; Zhang KJ; Wang YG; Jia XY; Liu XY
Cancer Biol Ther; 2010 Aug; 10(3):242-50. PubMed ID: 20574150
[TBL] [Abstract][Full Text] [Related]
18. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.
Kim J; Cho JY; Kim JH; Jung KC; Yun CO
Cancer Gene Ther; 2002 Sep; 9(9):725-36. PubMed ID: 12189522
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells.
Watanabe Y; Hashimoto Y; Kagawa S; Kawamura H; Nagai K; Tanaka N; Urata Y; Fujiwara T
Cancer Gene Ther; 2012 Nov; 19(11):767-72. PubMed ID: 22956040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
